News

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

Hummingbird Bioscience has won the Asia Pacific Trailblazer Award at the 2026 AI Discovery Awards…

Continue Reading

Hummingbird Bioscience Appoints Dipti Thakkar, PhD, as Chief Operating Officer

Hummingbird Bioscience today announced the internal appointment of Dipti Thakkar, PhD, as Chief Operating Officer.

Continue Reading

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs)…

Continue Reading

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today…

Continue Reading

Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today…

Continue Reading

Hummingbird Bioscience Announces Key Leadership Appointments

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today…

Continue Reading

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024

Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat…

Continue Reading